Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP681085.RADj2gVuPChIeJruzMuy40U1lXOq-UWlJQoa5zozTQCgI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP681085.RADj2gVuPChIeJruzMuy40U1lXOq-UWlJQoa5zozTQCgI130_assertion type Assertion NP681085.RADj2gVuPChIeJruzMuy40U1lXOq-UWlJQoa5zozTQCgI130_head.
- NP681085.RADj2gVuPChIeJruzMuy40U1lXOq-UWlJQoa5zozTQCgI130_assertion description "[Pharmacologic inhibitors of IP3R, MPTP opening, and cyclophilin D could have clinical implications for primary open-angle glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681085.RADj2gVuPChIeJruzMuy40U1lXOq-UWlJQoa5zozTQCgI130_provenance.
- NP681085.RADj2gVuPChIeJruzMuy40U1lXOq-UWlJQoa5zozTQCgI130_assertion evidence source_evidence_literature NP681085.RADj2gVuPChIeJruzMuy40U1lXOq-UWlJQoa5zozTQCgI130_provenance.
- NP681085.RADj2gVuPChIeJruzMuy40U1lXOq-UWlJQoa5zozTQCgI130_assertion SIO_000772 18614807 NP681085.RADj2gVuPChIeJruzMuy40U1lXOq-UWlJQoa5zozTQCgI130_provenance.
- NP681085.RADj2gVuPChIeJruzMuy40U1lXOq-UWlJQoa5zozTQCgI130_assertion wasDerivedFrom befree-2016 NP681085.RADj2gVuPChIeJruzMuy40U1lXOq-UWlJQoa5zozTQCgI130_provenance.
- NP681085.RADj2gVuPChIeJruzMuy40U1lXOq-UWlJQoa5zozTQCgI130_assertion wasGeneratedBy ECO_0000203 NP681085.RADj2gVuPChIeJruzMuy40U1lXOq-UWlJQoa5zozTQCgI130_provenance.